159 related articles for article (PubMed ID: 14510692)
21. Diabetes mellitus-cell transplantation and gene therapy approaches.
Halvorsen T; Levine F
Curr Mol Med; 2001 May; 1(2):273-86. PubMed ID: 11899076
[TBL] [Abstract][Full Text] [Related]
22. Islet amyloid polypeptide (IAPP) secretion from pancreatic islets isolated from non-obese diabetic (NOD) mice.
Karlsson E; Stridsberg M; Sandler S
Regul Pept; 1996 May; 63(1):39-45. PubMed ID: 8795087
[TBL] [Abstract][Full Text] [Related]
23. Histopathological and immunohistochemical analysis of the endocrine and exocrine pancreas in twelve cattle with insulin-dependent diabetes mellitus (IDDM).
Taniyama H; Hirayama K; Kagawa Y; Kurosawa T; Tajima M; Yoshino T; Furuoka H
J Vet Med Sci; 1999 Jul; 61(7):803-10. PubMed ID: 10458104
[TBL] [Abstract][Full Text] [Related]
24. Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism.
Grewal IS; Grewal KD; Wong FS; Wang H; Picarella DE; Janeway CA; Flavell RA
J Autoimmun; 2002; 19(1-2):9-22. PubMed ID: 12367555
[TBL] [Abstract][Full Text] [Related]
25. Specific inhibition of autoimmune T cell transmigration contributes to beta cell functionality and insulin synthesis in non-obese diabetic (NOD) mice.
Savinov AY; Rozanov DV; Strongin AY
J Biol Chem; 2007 Nov; 282(44):32106-11. PubMed ID: 17761671
[TBL] [Abstract][Full Text] [Related]
26. Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes.
Efrat S
Ann N Y Acad Sci; 1999 Jun; 875():286-93. PubMed ID: 10415575
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation.
Ren J; Jin P; Wang E; Liu E; Harlan DM; Li X; Stroncek DF
J Transl Med; 2007 Jan; 5():1. PubMed ID: 17201925
[TBL] [Abstract][Full Text] [Related]
28. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
[TBL] [Abstract][Full Text] [Related]
29. Correction of diabetic nod mice with insulinomas implanted within Baxter immunoisolation devices.
Loudovaris T; Jacobs S; Young S; Maryanov D; Brauker J; Johnson RC
J Mol Med (Berl); 1999 Jan; 77(1):219-22. PubMed ID: 9930967
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for diabetes: reinventing the islet.
Samson SL; Chan L
Trends Endocrinol Metab; 2006 Apr; 17(3):92-100. PubMed ID: 16504534
[TBL] [Abstract][Full Text] [Related]
31. Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.
Zhang C; Wang M; Racine JJ; Liu H; Lin CL; Nair I; Lau J; Cao YA; Todorov I; Atkinson M; Zeng D
Diabetes; 2010 Sep; 59(9):2228-36. PubMed ID: 20530743
[TBL] [Abstract][Full Text] [Related]
32. Glucose-regulated insulin production in hepatocytes.
Alam T; Sollinger HW
Transplantation; 2002 Dec; 74(12):1781-7. PubMed ID: 12499898
[TBL] [Abstract][Full Text] [Related]
33. Replacing murine insulin 1 with human insulin protects NOD mice from diabetes.
Elso CM; Scott NA; Mariana L; Masterman EI; Sutherland APR; Thomas HE; Mannering SI
PLoS One; 2019; 14(12):e0225021. PubMed ID: 31821343
[TBL] [Abstract][Full Text] [Related]
34. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.
Jun Y; Kang AR; Lee JS; Park SJ; Lee DY; Moon SH; Lee SH
Biomaterials; 2014 Jun; 35(17):4815-26. PubMed ID: 24636217
[TBL] [Abstract][Full Text] [Related]
35. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
Choi MS; Jung UJ; Yeo J; Kim MJ; Lee MK
Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice.
Yechoor V; Liu V; Paul A; Lee J; Buras E; Ozer K; Samson S; Chan L
Endocrinology; 2009 Nov; 150(11):4863-73. PubMed ID: 19819964
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
Diabetes; 1997 May; 46(5):750-7. PubMed ID: 9133540
[TBL] [Abstract][Full Text] [Related]
38. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
Rabinovitch A
Diabetes Metab Rev; 1998 Jun; 14(2):129-51. PubMed ID: 9679667
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for diabetes mellitus.
Docherty K
Clin Sci (Lond); 1997 Apr; 92(4):321-30. PubMed ID: 9176029
[TBL] [Abstract][Full Text] [Related]
40. Age-dependent sensitivity to streptozotocin of pancreatic islets isolated from female NOD mice.
Reddy S; Sandler S
Autoimmunity; 1995; 22(2):121-6. PubMed ID: 8722582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
